Arix Bioscience founds new portfolio company, Twelve Bio
LONDON: Arix Bioscience Plc, a global venture capital company focused on investing in and building breakthrough biotech companies, announced the foundation of a new portfolio company, Twelve Bio, which is developing novel engineered Cas12a nucleases for therapeutic gene editing. Arix…